Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2005
12/29/2005US20050288238 Benzocyclodecane derivatives with antitumor activity
12/29/2005US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/28/2005EP1608619A1 Muscarinic agonists
12/28/2005EP1495011B1 A semi-synthetic process for the preparation of n debenzoylpaclitaxel
12/28/2005EP1485057B1 Derivatives of azaspiro compounds for the treatment of pain
12/28/2005EP1049686B9 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
12/28/2005EP1002790B1 Sphingosine analogues
12/28/2005CN1714074A Process for producing aromatic nitrile compound
12/28/2005CN1233618C Benzoylcyclohexanone amine compounds with herbicidal activity
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005113558A3 Simple stereocontrolled synthesis of salinosporamide a
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005US20050282780 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/21/2005EP1606351A2 Cyanine dye labelling reagents with meso-substitution
12/21/2005EP1606249A2 Compounds, a process for their preparation and their use as dyes and pigments
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs
12/21/2005CN1711084A Substituted 4-alkoxyoxazol derivatives as PPAR agonists
12/21/2005CN1232511C Process for preparing oxazolyl acetate derivative and its salts
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/15/2005WO2005118561A1 Benzoxazolone derivatives, processes for preparing them and their uses
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118511A2 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/15/2005WO2005117817A1 M-phenylene diamine coupler components
12/15/2005WO2005080357A3 Oxazole derivatives, preparation and therapeutic use therof
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277632 2-Hydroxyethylamines 2-substituted by a hydroxy-N-heterocycle and N-substituted by an omega-phenyl-1,1-dimethylalkyl group: 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-ethyl}-2,2-dimethyl-4H-benzo[1,4]oxazin-3-one; betamimetics
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005DE10210195B4 Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz Using 1,3-diazaspiro [4,5] decane-2,4-dithione for treating pain
12/15/2005DE102004026732A1 m-Phenylendiamin-Kupplerkomponenten m-phenylenediamine coupler components
12/15/2005CA2567909A1 Benzoxazolone derivatives, processes for preparing them and their uses
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603902A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates
12/14/2005CN1231456C Process for preparing optically active cyclopropyl carboxylic acid derivative
12/14/2005CN1231440C Novel tricyclic compound
12/13/2005US6974875 Animal extracts; anticancer agents
12/13/2005US6974872 Process for production of piperidine derivatives
12/08/2005WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005116016A1 Compounds and compositions as ppar modulators
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115999A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama
12/08/2005WO2005115998A1 TYROSINE DERIVATIVES SUBSTITUTED BY ALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115148A1 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
12/08/2005WO2005009951A3 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
12/08/2005WO2004056315A8 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272786 Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272771 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272704 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005CA2565257A1 Thioether derivatives, their manufacture and use as pharmaceutical agents
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2563819A1 Compounds and compositions as ppar modulators
12/07/2005EP1601671A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
12/07/2005EP1294717B1 A thiazine oxazolidinone
12/07/2005EP1069115B1 Process for producing oxazolidin-2-one derivatives
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1230435C Heteroaryl-substd. heterocycles
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2160081C Manufacture of 4-aryl-2-perfluoroalkyl-3-oxazolin-5-one from arylglycine
12/01/2005WO2005113558A2 Simple stereocontrolled synthesis of salinosporamide a
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113523A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113521A1 Process of preparing substituted carbamates and intermediates thereof
12/01/2005WO2005113520A1 Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
12/01/2005WO2005113490A1 Sulfone-containing prodrugs
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005112913A1 Transthyretin stabilization
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267180 treatment/prevention of non-insulin dependent diabetes mellitus, lowing cholesterol, decrease blood pressure, counteract inflammatory atherosclerosis, metabolic disorders, polycystic ovary syndrome, liver disorders; S)-2-Ethoxy-3-[2-methyl-4-(5-methyl-2-o-tolyl-oxazol-4-ylmethoxy)-phenyl]-propionic acid
12/01/2005US20050267177 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267032 Sulfone-containing prodrugs
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005CA2566688A1 Transthyretin stabilization
11/2005
11/30/2005EP1599455A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1599453A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 210